VANGUARD GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for Iovance Biotherapeutics Inc Common Stock (IOVA)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Iovance Biotherapeutics Inc Common Stock
Symbol: IOVA
Shares outstanding: 334,352,960 shares
Disclosed Ownership: 25,076,472 shares
Ownership: 7.5%
Form type: SCHEDULE 13G/A
Filing time: 29 Jul 2025, 13:46:20 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	7.5%	25,076,472	0	158,020	Ashley Grim	Head of Global Fund Administration